| |
Latest 10 SEC filings (by transaction date) for XOMA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 10/24 | Jan 8/24 | Hughes Owen | Direct Ownership | Performance Stock Units | A - Grant, award or other under Rule 16b-3(d) | 275,000 | |
Oct 4/23 | Oct 3/23 | Sitko Bradley | Direct Ownership | Common Stock | P - Open market or private purchase | 250 | $13.89 |
Oct 4/23 | Oct 2/23 | Hughes Owen | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $13.83 |
Oct 4/23 | Oct 2/23 | Sitko Bradley | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $14.25 |
Sep 27/23 | Sep 26/23 | Hughes Owen | Direct Ownership | Common Stock | P - Open market or private purchase | 2,499 | $14.43 |
Sep 27/23 | Sep 25/23 | Hughes Owen | Direct Ownership | Common Stock | P - Open market or private purchase | 1 | $14.65 |
May 25/23 | May 24/23 | Hughes Owen | Direct Ownership | Depositary Shares - 8.375% B Cumulative Stock | P - Open market or private purchase | 1,032 | $23.79 |
May 25/23 | May 23/23 | Sitko Bradley | Direct Ownership | Common Stock | P - Open market or private purchase | 850 | $19.00 |
May 25/23 | May 23/23 | Hughes Owen | Direct Ownership | Depositary Shares - 8.375% B Cumulative Stock | P - Open market or private purchase | 768 | $23.49 |
May 25/23 | May 23/23 | Hughes Owen | Direct Ownership | Depositary Shares - 8.375% B Cumulative Stock | P - Open market or private purchase | 200 | $23.33 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for XOMA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 10/24 | Jan 8/24 | Hughes Owen | Direct Ownership | Performance Stock Units | A - Grant, award or other under Rule 16b-3(d) | 275,000 | |
Oct 4/23 | Oct 2/23 | Hughes Owen | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $13.83 |
Oct 4/23 | Oct 3/23 | Sitko Bradley | Direct Ownership | Common Stock | P - Open market or private purchase | 250 | $13.89 |
Oct 4/23 | Oct 2/23 | Sitko Bradley | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $14.25 |
Sep 27/23 | Sep 26/23 | Hughes Owen | Direct Ownership | Common Stock | P - Open market or private purchase | 2,499 | $14.43 |
Sep 27/23 | Sep 25/23 | Hughes Owen | Direct Ownership | Common Stock | P - Open market or private purchase | 1 | $14.65 |
May 25/23 | May 23/23 | Sitko Bradley | Direct Ownership | Common Stock | P - Open market or private purchase | 850 | $19.00 |
May 25/23 | May 24/23 | Hughes Owen | Direct Ownership | Depositary Shares - 8.375% B Cumulative Stock | P - Open market or private purchase | 1,032 | $23.79 |
May 25/23 | May 23/23 | Hughes Owen | Direct Ownership | Depositary Shares - 8.375% B Cumulative Stock | P - Open market or private purchase | 768 | $23.49 |
May 25/23 | May 23/23 | Hughes Owen | Direct Ownership | Depositary Shares - 8.375% B Cumulative Stock | P - Open market or private purchase | 200 | $23.33 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |